Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Nilotinib can cause skin issues like red bumps and hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Bicalutamide improves hair density in women safely.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

A new method to make finasteride for hair loss treatment was developed.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Finasteride may affect PNMT, causing side effects.

Newly made nicotinamide compounds could potentially treat cancer.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Finasteride was successfully synthesized from Pregnadienolone acetate.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

New hybrid compound found to effectively prevent hair loss.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.